|
|
|
LifeScienceHistory.com - Check us out on Instagram
New Jersey Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New JerseyLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Amneal Pharmaceuticals, Inc.
| | | Phone: | (908) 409-6822 | Fax: | (908) 947-3146 | Year Established: | 2002 | Ticker: | AMRX | Exchange: | NYSE | Main Contact: | Robert Stewart, President & CEO | | Other Contacts: | Deb M. Penza, Senior VP, Chief Compliance Officer Bryan M. Reasons, Senior VP & CFO Scott L. Hunter, VP, Specialty Sales and Marketing Sheldon Hirt, Senior VP, General Counsel Shankar Hariharan, Ph.D., Executive VP & CSO Robert Stewart, President Andrew S. Boyer, Executive VP, Commercial Operations Joseph Greer, Senior VP, Global Quality Management Miguel Gomez, Senior VP, Technical Operations
| | Company Description | Amneal Pharmaceuticals is a U.S.-based developer and manufacturer of high quality generic pharmaceuticals globally. The Company owns and operates manufacturing, R&D, packaging, sales and distribution facilities throughout the U.S. and abroad. | |
|
|
|
|
|